Home to about 60% of the world's population, the Asia Pacific region includes a diverse range of countries, many of which are dealing with the challenges of rapidly ageing societies. These factors have contributed to the rapid growth of the life sciences industry in the region, opening up opportunities for expansion and investment.
In 2020, Singapore's biomedical manufacturing output accounted for close to 11% of the nation's total manufacturing output at SGD 33.56 billion. Major pharmaceutical companies have also established their regional headquarters in Singapore's vibrant research ecosystem.
Join AmCham as we unpack the potential of the Asia Pacific's life sciences sector, focusing on the key trends and corporate real estate strategies and investment opportunities in the region.
For any enquires please contact the AmCham Programming and Events Team.
*CANCELLATION POLICY: No refunds will be provided for cancellations. Replacements will be accepted.